| Health / Medical Topics |
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
A cancer vaccine consisting of allogeneic, immortalized dendritic precursor cells derived from a patient with acute myelogenous leukemia (AML), with potential immunostimulatory and antineoplastic activities. Upon ex vivo stimulation and expansion of the precursor cells into mature, fully functional dendritic cells (DCs) and subsequent administration, the allogeneic AML antigen-expressing DC vaccine may elicit a potent cytotoxic T-cell (CTL) and antibody response against AML antigen-expressing cells, resulting in tumor cell death. (NCI Thesaurus)
YOU MAY ALSO LIKE
A population of allogeneic cytotoxic T-lymphocytes (CTLs) specifically reactive to human adenovirus (Ad) with potential immunomodulating and anti-adenoviral activities. Upon immunoprophylactic adoptive…
Taken from different individuals of the same species. Also called allogenic.
Allodepleted haploidentical T-lymphocytes transduced with the Gal-V pseudotyped retrovirus vector encoding SFG.iCasp9-2A-deltaCD19, with potential immune reconstitution property. SFG.iCasp9-2A-deltaCD19 contains the suicide gene…
A copper(l) complex used as an antiinflammatory drug and antiarthritic agent.
An antimitotic agent that binds to tubulin and inhibits tubulin polymerization and arrests proliferation of tumor cells.
A coded value specifying the method of assigning entities to groups or categories.
